Senti Biosciences, Inc. (SNTI)

Senti Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	33.8	48.28	35.93	57.62	56.03	30.54
Short-Term Investments	0.07	0.34	0.04	42.15	1.16	0.03
Cash & Short-Term Investments	33.88	48.61	35.97	99.77	57.19	30.56
Cash Growth	42.24%	35.15%	-63.95%	74.45%	87.13%	71.42%
Accounts Receivable	0.13	0.16	0.11	0.63	0.48	0.32
Other Receivables	2.09	1.65	17.59	-	-	-
Receivables	2.22	1.81	17.7	0.63	0.48	0.32
Prepaid Expenses	9.12	7.96	17.33	1.87	0.8	-
Other Current Assets	-	0.58	0.2	0.31	1.72	0.83
Total Current Assets	45.21	58.96	71.2	102.58	60.19	31.71
Property, Plant & Equipment	33.94	35.24	41.61	69.78	33.08	16.14
Other Long-Term Assets	3.63	3.64	6.67	8.43	3.43	0.5
Total Assets	82.78	97.84	119.48	180.79	96.7	48.35
Accounts Payable	1.56	1.45	1.25	1.37	5.19	0.91
Accrued Expenses	3.42	6.27	5.93	12.58	5.33	2
Current Portion of Leases	4.81	4.75	4.13	1.99	1.74	1.52
Current Unearned Revenue	0.51	0.66	0.99	0.8	1.66	-
Other Current Liabilities	0.42	0.01	0.38	1.32	0.63	0.44
Total Current Liabilities	10.73	13.15	12.67	18.05	14.54	4.87
Long-Term Leases	27.63	28.89	33.54	35.1	20.99	12.53
Long-Term Unearned Revenue	6.41	-	-	-	0.18	-
Other Long-Term Liabilities	0.15	5.05	6.36	0.37	0.62	-
Total Liabilities	44.92	47.09	52.57	53.53	36.33	17.4
Common Stock	0	0	0	0	-	0
Additional Paid-In Capital	349.1	322.78	311.26	300.54	3.62	1.04
Retained Earnings	-311.25	-297.13	-244.34	-173.29	-115.08	-59.76
Comprehensive Income & Other	-	-	-	0	-	-
Total Common Equity	37.86	25.65	66.91	127.26	-111.46	-58.71
Shareholders' Equity	37.86	50.76	66.91	127.26	60.38	30.95
Total Liabilities & Equity	82.78	97.84	119.48	180.79	96.7	48.35
Total Debt	32.45	33.64	37.67	37.09	22.73	14.05
Net Cash (Debt)	1.43	14.97	-1.7	62.68	34.46	16.51
Net Cash Growth	-	-	-	81.89%	108.68%	446.97%
Net Cash Per Share	0.24	3.26	-0.38	24.01	118.33	11.91
Filing Date Shares Outstanding	26.08	26	4.57	4.42	1.52	1.45
Total Common Shares Outstanding	26	4.83	4.57	4.41	1.52	1.45
Working Capital	34.49	45.82	58.53	84.53	45.65	26.84
Book Value Per Share	1.46	5.31	14.64	28.88	-73.38	-40.48
Tangible Book Value	37.86	25.65	66.91	127.26	-111.46	-58.71
Tangible Book Value Per Share	1.46	5.31	14.64	28.88	-73.38	-40.48
Machinery	8.35	8.18	8.87	8.56	5.54	3.91
Construction In Progress	-	-	-	43.89	8.05	0.23
Leasehold Improvements	22.66	22.66	22.65	1.87	0.43	0.16

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q